ARTICLE | Company News
CFIUS gives Novartis, Endocyte deal a pass -- for now
December 21, 2018 8:46 PM UTC
A Dec. 14 decision by CFIUS to neither clear nor initiate review of the $2.1 billion acquisition of Endocyte Inc. (NASDAQ:ECYT) by Novartis AG (NYSE:NVS; SIX:NOVN) provides little clarity as to how far the committee will tread into biotech territory.
The deal closed a week later...